Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
Recruiting
Observational Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Observational
- Participants needed
- 459 (estimated)
- Sponsor
- Vastra Gotaland Region · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Magnetic tracer injected before preoperative chemotherapy in breast cancer patients for sentinel lymph node detection. Also, magnetic tracer in combination with magnetic clip for index node identification.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* Patients 18 years of age or older.
* Patients with breast cancer planned to undergo NACT with
* planned sentinel lymph node dissection (SLND), or
* targeted axillary lymph node dissection (TAD), in conjunction with the
* breast surgery after NACT.
Exclusion Criteria:
* …
Contacts